Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Madia Lozupone, Francesco Panza, Eleonora Stella, Maddalena La Montagna, Paola Bisceglia, Giuseppe Miscio, Ilaria Galizia, Antonio Daniele, Lazzaro di Mauro, Antonello Bellomo, Giancarlo Logroscino, Antonio Greco & Davide Seripa. (2017) Pharmacogenetics of neurological and psychiatric diseases at older age: has the time come?. Expert Opinion on Drug Metabolism & Toxicology 13:3, pages 259-277.
Read now
Read now
Hee Jin Kim & Beomseok Jeon. (2016) How close are we to individualized medicine for Parkinson’s disease?. Expert Review of Neurotherapeutics 16:7, pages 815-830.
Read now
Read now
Pothitos M Pitychoutis, Nikolaos Kokras, Despina Sanoudou, Christina Dalla & Zeta Papadopoulou-Daifoti. (2013) Pharmacogenetic considerations for late life depression therapy. Expert Opinion on Drug Metabolism & Toxicology 9:8, pages 989-999.
Read now
Read now
Philip Gerretsen, Daniel J. Müller, Arun Tiwari, David Mamo & Bruce G. Pollock. (2009) The intersection of pharmacology, imaging, and genetics in the development of personalized medicine
. Dialogues in Clinical Neuroscience 11:4, pages 363-376.
Read now
Read now
Articles from other publishers (21)
Parnika Prashasti Saxena. (2022) Commentary on ‘Perspectives on the Clinical Use of Pharmacogenetic Testing in Late-Life Mental Healthcare: A Survey of the American Association of Geriatric Psychiatry Membership’. The American Journal of Geriatric Psychiatry 30:5, pages 572-574.
Crossref
Crossref
Donald D Chang, Harris A Eyre, Ryan Abbott, Michael Coudreaut, Bernhard T Baune, Jeffrey A Shaman, Helen Lavretsky, Eric J Lenze, David A Merrill, Ajeet B Singh, Benoit H Mulsant, Charles F ReynoldsIIIIII, Daniel J Müller & Chad Bousman. (2018) Pharmacogenetic guidelines and decision support tools for depression treatment: application to late-life. Pharmacogenomics 19:16, pages 1269-1284.
Crossref
Crossref
Miriam Saiz-Rodríguez, Carmen Belmonte, Manuel Román, Dolores Ochoa, Dora Koller, María Talegón, María C. Ovejero-Benito, Rosario López-Rodríguez, Teresa Cabaleiro & Francisco Abad-Santos. (2018) Effect of Polymorphisms on the Pharmacokinetics, Pharmacodynamics and Safety of Sertraline in Healthy Volunteers. Basic & Clinical Pharmacology & Toxicology 122:5, pages 501-511.
Crossref
Crossref
Lidan Dong, Ling Xu, Yanfei Li, Yinghua Lv, Hongxia Liu, Yunfei Li, Fengyan Xu, Junyi Wu, Qingshan Zheng & Lujin Li. (2018) Model-based comparing efficacy of fluoxetine between elderly and non-elderly participants with major depressive disorder. Journal of Affective Disorders 229, pages 224-230.
Crossref
Crossref
Christopher F. Sharpley, David R.H. Christie, Vicki Bitsika, Nicholas M. Andronicos, Linda L. Agnew & Mary E. McMillan. (2017) Does psychological resilience buffer against the link between the 5-HTTLPR polymorphism and depression following stress. Physiology & Behavior 180, pages 53-59.
Crossref
Crossref
Davide Seripa, Andrea Pilotto, Giulia Paroni, Andrea Fontana, Grazia D’Onofrio, Carolina Gravina, Maria Urbano, Leandro Cascavilla, Francesco Paris, Francesco Panza, Alessandro Padovani & Alberto Pilotto. (2015) Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life. Journal of Psychopharmacology 29:5, pages 623-633.
Crossref
Crossref
Jeff S. Kruk, Maryam S. Vasefi, Nyasha Gondora, Nawaz Ahmed, John J. Heikkila & Michael A. Beazely. (2015) Fluoxetine-induced transactivation of the platelet-derived growth factor type β receptor reveals a novel heterologous desensitization process. Molecular and Cellular Neuroscience 65, pages 45-51.
Crossref
Crossref
Paulo R. Shiroma, Maureen S. Drews, Jennifer R. Geske & David A. Mrazek. (2014) SLC6A4 Polymorphisms and Age of Onset in Late-life Depression on Treatment Outcomes with Citalopram: A Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Report. The American Journal of Geriatric Psychiatry 22:11, pages 1140-1148.
Crossref
Crossref
A. Sicras-Mainar, P. Guijarro, B. Armada, M. Blanca-Tamayo & R. Navarro-Artieda. (2020) Influence of combinations of drugs that act on the CYP2D6 metabolic pathway in the treatment of major depressive disorder: A population-based study. European Psychiatry 29:6, pages 331-337.
Crossref
Crossref
P Scibona, F Angriman, C Vazquez, BL Ferreyro, AG Perelsztein, VA Simonovich, JR Jauregui, CG Musso & WH Belloso. (2014) Individualization of drug therapy in older people. Reviews in Clinical Gerontology 24:2, pages 145-157.
Crossref
Crossref
Christina Pataky-Forsyth, Philip Gerretsen & Bruce Pollock. 2014. Handbook of Personalized Medicine. Handbook of Personalized Medicine
341
374
.
Davide Seripa, Francesco Panza, Grazia D'Onofrio, Giulia Paroni, Alessandra Bizzarro, Andrea Fontana, Francesco Paris, Leandro Cascavilla, Massimiliano Copetti, Carlo Masullo & Alberto Pilotto. (2013) The Serotonin Transporter Gene Locus in Late-Life Major Depressive Disorder. The American Journal of Geriatric Psychiatry 21:1, pages 67-77.
Crossref
Crossref
Carmen Andreescu & Charles F. Reynolds. (2012) Depresión a una edad avanzada: tratamiento basado en la evidencia y nuevos caminos prometedores para la investigación y la práctica clínica. Psiquiatría Biológica 19:4, pages 116-126.
Crossref
Crossref
Sharon L. Naismith, Louisa M. Norrie, Loren Mowszowski & Ian B. Hickie. (2012) The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features. Progress in Neurobiology 98:1, pages 99-143.
Crossref
Crossref
Daniela Haeusler, Markus Mitterhauser & Wolfgang Wadsak. 2012. Radiochemical Syntheses. Radiochemical Syntheses
285
296
.
H P Rang, M M Dale, J M Ritter, R J Flower & G Henderson. 2012. Rang & Dale's Pharmacology. Rang & Dale's Pharmacology
564
583
.
Maurizio Cardelli, Francesca Marchegiani, Andrea Corsonello, Fabrizia Lattanzio & Mauro Provinciali. (2013) A Review of Pharmacogenetics of Adverse Drug Reactions in Elderly People. Drug Safety 35:S1, pages 3-20.
Crossref
Crossref
Carmen Andreescu & Charles F. ReynoldsIIIIII. (2011) Late-life Depression: Evidence-based Treatment and Promising New Directions for Research and Clinical Practice. Psychiatric Clinics of North America 34:2, pages 335-355.
Crossref
Crossref
Francisco J. de Abajo. (2011) Effects of Selective Serotonin Reuptake Inhibitors on Platelet Function. Drugs & Aging 28:5, pages 345-367.
Crossref
Crossref
Richard Levy. (2010) Medication use by ethnic and racial groups: policy implications. Journal of Pharmaceutical Health Services Research 1:1, pages 15-22.
Crossref
Crossref
Olga O. Yevtushenko & Gavin P. Reynolds. 2010. Handbook of the Behavioral Neurobiology of Serotonin. Handbook of the Behavioral Neurobiology of Serotonin
791
806
.